A detailed history of Ancora Advisors, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Ancora Advisors, LLC holds 1,522 shares of ANIX stock, worth $4,839. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,522
Previous 1,522 -0.0%
Holding current value
$4,839
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$3.78 - $5.81 $1,890 - $2,905
-500 Reduced 24.73%
1,522 $6,000
Q2 2022

Aug 15, 2022

BUY
$2.55 - $4.1 $3,881 - $6,240
1,522 Added 304.4%
2,022 $6,000
Q1 2022

May 16, 2022

BUY
$2.5 - $3.42 $1,250 - $1,710
500 New
500 $1,000
Q1 2022

May 13, 2022

SELL
$2.5 - $3.42 $1,250 - $1,710
-500 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$2.88 - $5.5 $1,440 - $2,750
500 New
500 $1,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $97.5M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.